BiotechTube
Home/Monte Rosa Therapeutics/John Castle
JC

John Castle

Chief Data and Information Officer

Monte Rosa Therapeutics

Therapeutic Areas

OncologyImmunologyInflammation

Monte Rosa Therapeutics Pipeline

DrugIndicationPhase
MRT-6160Immune-mediated Diseases (e.g., Multiple Sclerosis, Rheumatoid Arthritis, IBD)Phase 1
MRT-8102IL-1β/NLRP3 driven Inflammatory DiseasesPhase 1
MRT-2359Castration-resistant Prostate CancerPhase 1/2
Next Generation (NEK7)IL-1β/NLRP3 driven Inflammatory DiseasesPreclinical

Leadership Team at Monte Rosa Therapeutics

MW
Markus Warmuth
Chief Executive Officer
ST
Sharon Townson
Chief Scientific Officer
View full Monte Rosa Therapeutics profile